HCA Healthcare, Inc. Stock: price and directors' dealings · United States · SEC (Form 4)Track the HCA Healthcare, Inc. stock price and the full management transaction log of the company, a listed equity based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, HCA Healthcare, Inc. has recorded 275 reports. Market capitalisation: €2.5bn. The latest transaction was filed on 28 August 2026 (J). Among the most active insiders: Cuffe Michael S.. Every trade is openly available.
Analyst consensus: bullish or bearish? Analysts rate HCA Healthcare, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$62.05.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,763 of 29,063 companies
FCF yld -3.8%
Earn yld -4.8%
EV/EBITDA ·
ROE -40%
Gross mgn 71%
Net mgn -0.3%
Debt/EBITDA ·
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 28 August 2026
All Executives275 Thresholds0 Prospectus0 Other0
Declarations 275 total
● EVP & Chief Legal & Admin Off. · Executives · 26 Aug 2026
7,769 shares @ US$429.00 Common Stock SEC:0001193125-26-374693:0
◆ Director · Executives · 28 Apr 2026
809 shares 0Common Stock SEC:0001193125-26-197734:0
◆ Director · Executives · 28 Apr 2026
509 shares 0Common Stock SEC:0001193125-26-197746:0
◆ Director · Executives · 28 Apr 2026
1,041 shares 0Common Stock, par value $0.01 per share SEC:0001140361-26-018352:0
◆ Director · Executives · 28 Apr 2026
809 shares 0Common Stock, par value $0.01 per share SEC:0001140361-26-018355:0
◆ Director · Executives · 28 Apr 2026
809 shares 0Common Stock SEC:0001193125-26-197757:0
◆ Director · Executives · 28 Apr 2026
925 shares 0Common Stock SEC:0001193125-26-197763:0
◆ Director · Executives · 28 Apr 2026
509 shares 0Common Stock SEC:0001193125-26-197773:0
◆ Director · Executives · 28 Apr 2026
509 shares 0Common Stock SEC:0001193125-26-197781:0
◇ EVP & Chief Legal & Admin Off. · Executives · 13 Feb 2026
5,000 shares @ US$236.61 25.4% of flow Common Stock SEC:0001193125-26-057701:0
◆ SVP & Controller · Executives · 10 Feb 2026
3,350 shares 0Common Stock SEC:0001193125-26-049224:0
◆ SVP & Chief Nurse Executive · Executives · 10 Feb 2026
1,676 shares 0Common Stock SEC:0001193125-26-049221:0
◆ EVP & Chief Legal & Admin Off. · Executives · 10 Feb 2026
8,372 shares 0Common Stock SEC:0001193125-26-049217:0
◆ EVP and CFO · Executives · 10 Feb 2026
5,026 shares 0Common Stock SEC:0001193125-26-049208:0
◆ CEO · Executives · 10 Feb 2026
54,934 shares 0Common Stock SEC:0001193125-26-049200:0
◆ EVP and COO · Executives · 10 Feb 2026
15,696 shares 0Common Stock SEC:0001193125-26-049197:0
◆ EVP and Chief Clinical Officer · Executives · 10 Feb 2026
9,628 shares 0Common Stock SEC:0001193125-26-049186:0
◆ SVP & Chief Human Res. Officer · Executives · 10 Feb 2026
7,116 shares 0Common Stock SEC:0001193125-26-049184:0
36,629,188 shares 0Common Stock, par value $0.01 per share SEC:0001140361-26-004682:0
36,629,188 shares Common Stock, par value $0.01 per share SEC:0001140361-26-004686:0
● Director · Executives · 6 Feb 2026
36,629,188 shares Common Stock, par value $0.01 per share SEC:0001140361-26-004685:0
● Director · Executives · 6 Feb 2026
36,629,188 shares Common Stock, par value $0.01 per share SEC:0001140361-26-004684:0
36,629,188 shares Common Stock, par value $0.01 per share SEC:0001140361-26-004683:0
36,629,188 shares Common Stock, par value $0.01 per share SEC:0001140361-26-004681:0
◇ SVP & Controller · Executives · 5 Feb 2026
10,670 shares @ US$139.06 24.1% of flow Common Stock SEC:0001193125-26-043147:0
25 of 275 declarations
Load more (250 remaining) 关于 HCA Healthcare, Inc. HCA Healthcare, Inc.(股票代码HCA)是美国最大的营利性医疗服务集团之一,在纽约证券交易所(美国)上市。公司总部位于田纳西州纳什维尔,由Thomas Frist Sr.博士、Thomas Frist Jr.博士和Jack C. Massey于1968年创立。其最初的使命是建立一个以规模、运营纪律和临床质量为基础的医院护理新模式。这一创始精神至今仍塑造着HCA Healthcare的战略,使其成为美国医院和急症护理市场长期以来的基准。([hcahealthcare.com](https://hcahealthcare.com/about/our-history.dot?utm_source=openai))
HCA Healthcare运营着一个广泛的医疗网络,包括医院、门诊手术中心、独立急诊室、紧急护理中心、医生诊所和其他门诊护理场所。其业务主要集中在美国,并在英国设有分支机构。公司将自己描述为一个学习型医疗系统,利用大量的患者就诊数据来支持临床改进、研究和运营效率。([investor.hcahealthcare.com](https://investor.hcahealthcare.com/news/news-details/2026/HCA-Healthcare-Named-a-Worlds-Most-Admired-Company-by-Fortune-for-the-12th-Consecutive-Year/default.aspx?utm_source=openai))
从竞争角度来看,HCA的优势在于其规模、综合交付模式、广泛的地理覆盖范围以及在门诊护理之外扩展高难度专科服务的能力。该集团还投资了旨在改善其网络内护理协调和生产力的数字和临床系统。对于投资者而言,这种组合至关重要,因为它在一个高度分散的美国医疗保健领域内支持了多元化的收入基础,同时还赋予HCA在采购、人员配置和网络优化方面的杠杆作用。([investor.hcahealthcare.com](https://investor.hcahealthcare.com/news/news-details/2024/HCA-Healthcare-Releases-2024-Annual-Impact-Report/default.aspx?utm_source=openai))
近期发展突显了公司的运营势头和战略重点。在2026年第一季度,HCA报告收入为19.109 billion美元,同比增长4.3%,归属于HCA的净利润为1.620 billion美元,运营现金流增长22.0%。管理层还指出入院人数和急诊就诊量适度增长,同时提及季节性和天气相关因素对业务量的压力。2025年,HCA继续强调社区投资、护理教育支持和医疗劳动力倡议,这既反映了其社会足迹,也反映了该行业面临的劳动力挑战。([investor.hcahealthcare.com](https://investor.hcahealthcare.com/news/news-details/2026/HCA-Healthcare-Reports-First-Quarter-2026-Results/default.aspx?utm_source=openai))